U.S. stocks opened moderately higher on Wednesday, boosted by a tamer-than-expected inflation reading and blowout quarterly ...

Geojit Financial Services shares fell over 6% after disappointing Q1 FY26 results, with net profit dropping 37% ...

The upcoming second-quarter earnings season is expected to shift the focus of Wall Street from the ongoing trade war to the ...

ASML Holding N.V. beats Q2 expectations with strong bookings and 2025 guidance. Click for my updated look at ASML earnings ...

Moody's (MCO) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended June 2025. This widely-known consensus outlook gives a good ...

Inflation, tariffs, and trade wars have investors seeking resilient investments. Click here to learn about 5 top stocks.

JNJ eyes Q2 growth with strong drug sales and new launches, but Stelara biosimilars and MedTech headwinds loom.

Trump’s tariffs and the trade war continue to roil global markets. Follow along for live updates on the Dow, S&P 500 and Nasdaq.

Alternatively, if you seek upside with a smoother journey than a single stock like Levi Strauss, consider the High Quality ...

The drug and medical device maker Johnson & Johnson kicked off the healthcare earnings season with a better-than-anticipated ...

Profits for S&P 500 companies in the second quarter are expected to rise 5.8%, according to LSEG data, down from a forecast ...

Investing.com - The second-quarter earnings season is likely to show the first material impact on Corporate America from an incremental rise in U.S. tariffs, according to analysts at Barclays. In a ...